Nuvation Bio NUVB Stock
Nuvation Bio Price Chart
Nuvation Bio NUVB Financial and Trading Overview
| Nuvation Bio stock price | 6.6 USD |
| Previous Close | 6.11 USD |
| Open | 6.3 USD |
| Bid | 6.46 USD x 390000 |
| Ask | 6.47 USD x 490000 |
| Day's Range | 6.21 - 6.62 USD |
| 52 Week Range | 2.18 - 9.75 USD |
| Volume | 3.21M USD |
| Avg. Volume | 6.44M USD |
| Market Cap | 2.27B USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.43 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.89 USD |
NUVB Valuation Measures
| Enterprise Value | 1.9B USD |
| Trailing P/E | N/A |
| Forward P/E | -107.833336 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.371202 |
| Price/Book (mrq) | 7.040261 |
| Enterprise Value/Revenue | 11.187 |
| Enterprise Value/EBITDA | -14.029 |
Trading Information
Nuvation Bio Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 167.82% |
| S&P500 52-Week Change | 18.95% |
| 52 Week High | 9.75 USD |
| 52 Week Low | 2.18 USD |
| 50-Day Moving Average | 5.59 USD |
| 200-Day Moving Average | 5.71 USD |
NUVB Share Statistics
| Avg. Volume (3 month) | 6.44M USD |
| Avg. Daily Volume (10-Days) | 5.96M USD |
| Shares Outstanding | 350.12M |
| Float | 256.75M |
| Short Ratio | 6.13 |
| % Held by Insiders | 18.59% |
| % Held by Institutions | 65.08% |
| Shares Short | 55.67M |
| Short % of Float | 26.46% |
| Short % of Shares Outstanding | 15.98% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -88.18% |
| Operating Margin (ttm) | -161.062% |
| Gross Margin | 88.17% |
| EBITDA Margin | -79.74% |
Management Effectiveness
| Return on Assets (ttm) | -12.36% |
| Return on Equity (ttm) | -47.80% |
Income Statement
| Revenue (ttm) | 169.9M USD |
| Revenue Per Share (ttm) | 0.49 USD |
| Quarterly Revenue Growth (yoy) | 555.60% |
| Gross Profit (ttm) | 149.81M USD |
| EBITDA | -135480992 USD |
| Net Income Avi to Common (ttm) | -149827008 USD |
| Diluted EPS (ttm) | -0.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 660.96M USD |
| Total Cash Per Share (mrq) | 1.88 USD |
| Total Debt (mrq) | 416.26M USD |
| Total Debt/Equity (mrq) | 163.97 USD |
| Current Ratio (mrq) | 8.373 |
| Book Value Per Share (mrq) | 0.919 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -120522000 USD |
| Levered Free Cash Flow (ttm) | -111720496 USD |
Profile of Nuvation Bio
| Country | United States |
| State | NY |
| City | New York |
| Address | 1500 Broadway |
| ZIP | 10036 |
| Phone | 332 208 6102 |
| Website | https://www.nuvationbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 298 |
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
Q&A For Nuvation Bio Stock
What is a current NUVB stock price?
Nuvation Bio NUVB stock price today per share is 6.6 USD.
How to purchase Nuvation Bio stock?
You can buy NUVB shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nuvation Bio?
The stock symbol or ticker of Nuvation Bio is NUVB.
Which industry does the Nuvation Bio company belong to?
The Nuvation Bio industry is Biotechnology.
How many shares does Nuvation Bio have in circulation?
The max supply of Nuvation Bio shares is 336.6M.
What is Nuvation Bio Price to Earnings Ratio (PE Ratio)?
Nuvation Bio PE Ratio is now.
What was Nuvation Bio earnings per share over the trailing 12 months (TTM)?
Nuvation Bio EPS is -0.43 USD over the trailing 12 months.
Which sector does the Nuvation Bio company belong to?
The Nuvation Bio sector is Healthcare.
Nuvation Bio NUVB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE Composite Index
NYA
US
|
24465.62 USD — |
-0.2
|
— — | 24460.42 USD — | 24600.48 USD — | — - | — — |
- {{ link.label }} {{link}}
